Remarkably, the focal adhesion kinase (FAK)/Pl3K-Akt signaling pathway and JAK-STAT signaling pathway were uniquely identified in S:E fusion-positive prostate cancer (Figure 1). Here, PTK2 is linked to prostate carcinoma.